File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.clinbiochem.2011.07.014
- Scopus: eid_2-s2.0-80052926548
- PMID: 21851814
- WOS: WOS:000295424500013
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A comprehensive HBV array for the detection of HBV mutants and genotype
Title | A comprehensive HBV array for the detection of HBV mutants and genotype |
---|---|
Authors | |
Keywords | AS-APEX Drug-resistant mutations Genotype HBV array |
Issue Date | 2011 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinbiochem |
Citation | Clinical Biochemistry, 2011, v. 44 n. 14-15, p. 1253-1260 How to Cite? |
Abstract | Objective: To develop a comprehensive hepatitis B virus (HBV) array providing simultaneous analysis of 8 genotypes, 47 mutations of reverse-transcriptase polymerase gene and 18 mutations of S gene. Method: Oligonucleotides corresponding to various HBV-normal and -mutant sequences were spotted onto pre-treated glass slides. Single-stranded templates of the HBV gene fragment were prepared from serum-DNA of HBV-infected patients by 2-staged PCR and subjected to allele-specific arrayed-primer extension with Cy5-dCTP. Fluorescein-labelled products were scanned at 670 nm. Results: Comparative analysis of 100 unrelated samples using the array and a commercial kit, revealed 44 with additional mutations from the array, these were confirmed by sequencing. Analysis of 381 samples from 45 patients during 1-3 years of anti-viral therapy showed improved sensitivity with detection of drug-resistant mutations months before clinical relapse. The lower detection limit was 28 copies/mL. Conclusion: The array is better than many existing methods as it provides both mutations and genotype data in a single analysis. © 2011 The Canadian Society of Clinical Chemists. |
Persistent Identifier | http://hdl.handle.net/10722/142386 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.703 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, K | en_HK |
dc.contributor.author | Yam, I | en_HK |
dc.contributor.author | Yuen, J | en_HK |
dc.contributor.author | Yuen, MF | en_HK |
dc.contributor.author | Lai, CL | en_HK |
dc.contributor.author | Alexander, GJ | en_HK |
dc.contributor.author | Chan, TK | en_HK |
dc.contributor.author | Chan, V | en_HK |
dc.date.accessioned | 2011-10-28T02:44:52Z | - |
dc.date.available | 2011-10-28T02:44:52Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Clinical Biochemistry, 2011, v. 44 n. 14-15, p. 1253-1260 | en_HK |
dc.identifier.issn | 0009-9120 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/142386 | - |
dc.description.abstract | Objective: To develop a comprehensive hepatitis B virus (HBV) array providing simultaneous analysis of 8 genotypes, 47 mutations of reverse-transcriptase polymerase gene and 18 mutations of S gene. Method: Oligonucleotides corresponding to various HBV-normal and -mutant sequences were spotted onto pre-treated glass slides. Single-stranded templates of the HBV gene fragment were prepared from serum-DNA of HBV-infected patients by 2-staged PCR and subjected to allele-specific arrayed-primer extension with Cy5-dCTP. Fluorescein-labelled products were scanned at 670 nm. Results: Comparative analysis of 100 unrelated samples using the array and a commercial kit, revealed 44 with additional mutations from the array, these were confirmed by sequencing. Analysis of 381 samples from 45 patients during 1-3 years of anti-viral therapy showed improved sensitivity with detection of drug-resistant mutations months before clinical relapse. The lower detection limit was 28 copies/mL. Conclusion: The array is better than many existing methods as it provides both mutations and genotype data in a single analysis. © 2011 The Canadian Society of Clinical Chemists. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/clinbiochem | en_HK |
dc.relation.ispartof | Clinical Biochemistry | en_HK |
dc.subject | AS-APEX | en_HK |
dc.subject | Drug-resistant mutations | en_HK |
dc.subject | Genotype | en_HK |
dc.subject | HBV array | en_HK |
dc.subject.mesh | Carbocyanines | en_HK |
dc.subject.mesh | Deoxycytosine Nucleotides | en_HK |
dc.subject.mesh | Drug Resistance, Viral - genetics | en_HK |
dc.subject.mesh | Follow-Up Studies | en_HK |
dc.subject.mesh | Genotype | en_HK |
dc.subject.mesh | Hepatitis B - drug therapy - genetics - virology | en_HK |
dc.subject.mesh | Hepatitis B virus - genetics | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Limit of Detection | en_HK |
dc.subject.mesh | Mutation | en_HK |
dc.subject.mesh | Oligonucleotide Array Sequence Analysis - methods | en_HK |
dc.subject.mesh | Polymerase Chain Reaction - methods | en_HK |
dc.subject.mesh | RNA-Directed DNA Polymerase - genetics | en_HK |
dc.subject.mesh | Sensitivity and Specificity | en_HK |
dc.subject.mesh | Viral Envelope Proteins - genetics | en_HK |
dc.title | A comprehensive HBV array for the detection of HBV mutants and genotype | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Chan, K: kaimin@hkucc.hku.hk | en_HK |
dc.identifier.email | Yuen, MF: mfyuen@hku.hk | en_HK |
dc.identifier.email | Lai, CL: hrmelcl@hku.hk | en_HK |
dc.identifier.email | Chan, V: vnychana@hkucc.hku.hk | en_HK |
dc.identifier.authority | Chan, K=rp00489 | en_HK |
dc.identifier.authority | Yuen, MF=rp00479 | en_HK |
dc.identifier.authority | Lai, CL=rp00314 | en_HK |
dc.identifier.authority | Chan, V=rp00320 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.clinbiochem.2011.07.014 | en_HK |
dc.identifier.pmid | 21851814 | - |
dc.identifier.scopus | eid_2-s2.0-80052926548 | en_HK |
dc.identifier.hkuros | 196648 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-80052926548&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 44 | en_HK |
dc.identifier.issue | 14-15 | en_HK |
dc.identifier.spage | 1253 | en_HK |
dc.identifier.epage | 1260 | en_HK |
dc.identifier.isi | WOS:000295424500013 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Chan, K=7406032228 | en_HK |
dc.identifier.scopusauthorid | Yam, I=6603358817 | en_HK |
dc.identifier.scopusauthorid | Yuen, J=7102620480 | en_HK |
dc.identifier.scopusauthorid | Yuen, MF=7102031955 | en_HK |
dc.identifier.scopusauthorid | Lai, CL=7403086396 | en_HK |
dc.identifier.scopusauthorid | Alexander, GJ=7401920548 | en_HK |
dc.identifier.scopusauthorid | Chan, TK=7402687762 | en_HK |
dc.identifier.scopusauthorid | Chan, V=7202654865 | en_HK |
dc.identifier.citeulike | 9628930 | - |
dc.identifier.issnl | 0009-9120 | - |